Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
Health and Me on MSN
Potential 'Functional Cure' For Hepatitis B: Trial Give Hope To Millions
The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...
A new hepatitis B drug shows promise as a potential functional cure, allowing some patients to stop treatment while ...
Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of ...
After treatment with bepirovirsen, however, 19% of patients achieved the strictly defined “functional cure” criteria. For the ...
The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...
Hepatitis B is sometimes referred to as the "silent killer" because people often lack symptoms – and yet the severe, long-term form of the disease can cause liver failure and death. But new evidence ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without showing signs of the dangerous virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results